title: Reversible serum carcinoembryogenic antigen (CEA) elevation due to orlistat use: A case report.
authors.forename: Gustavo dos Santos
authors.initials: Gdos S
authors.lastname: Fernandes
authors.forename: Atur
authors.initials: A
authors.lastname: Katz
authors.forename: Aknar
authors.initials: A
authors.lastname: Calabrich
authors.forename: Paulo M
authors.initials: PM
authors.lastname: Hoff
mesh_terms: D000368:Aged; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D003110:Colonic Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000556:secondary; D000077403:Orlistat; D003074:Solitary Pulmonary Nodule / Q000556:secondary
chemical_list: D019440:Anti-Obesity Agents; D002272:Carcinoembryonic Antigen; D007783:Lactones; D000077403:Orlistat